Fibrogen Inc. diskutieren
Fibrogen Inc.
WKN: A12EZ0 / Symbol: FGEN / Name: FibroGen / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
1,08 €
-4,59 %
FibroGen, Inc. (NASDAQ: FGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FGEN provided by MarketBeat
FibroGen, Inc. (NASDAQ: FGEN) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $2.00 price target on the stock, down previously from $4.00.
Ratings data for FGEN provided by MarketBeat
Neueste Beiträge
Wedbush in Xencor Inc. diskutieren